Comac Medical has successfully completed Phase 1 of Horizon 2020 SME Instrument and has submitted the project report which has been approved by the European Commission.
Horizon 2020 SME Instrument Phase 1 successfully completed
August 27, 2015
Share:
News
In today’s fast-evolving biotech landscape, choosing the right biotech CRO (Contract Research Organization) can be the single most...
[Sofia, Bulgaria] – Comac Medical is pleased to announce that Steve Angus will be joining Comac Medical as...
Summer brings sunlit days, long evenings, and countless opportunities to enjoy the outdoors. Yet for the pharmaceutical and...